Literature DB >> 28740610

Importance of a 4-Alkyl Substituent for Activity in the Englerin Series.

Daniel C Elliott1, John A Beutler2, Kathlyn A Parker1.   

Abstract

The ring closing metathesis/transannular etherification approach to the englerin nucleus was adapted to provide two key intermediates for analogue synthesis: the 4-desmethyl Δ5,6 tricycle and the 4-oxo Δ5,6 tricycle. The former was elaborated to 4-desmethyl englerin A and the latter served as a common precursor for englerin A, 4-ethyl englerin A, and 4-isopropyl englerin A. 4-Desmethyl englerin A was less active than the natural product by an order of magnitude, but the 4-ethyl and 4-isopropyl analogues were comparable in activity to englerin A. These results are consistent with the premise that the 4-alkyl group enforces the binding conformation of the cinnamoyl ester substituent. Furthermore, they suggest that 4-alkyl englerin structures may prove to be useful tool compounds.

Entities:  

Keywords:  Englerin; NCI 60 screen; SAR; etherification

Year:  2017        PMID: 28740610      PMCID: PMC5512125          DOI: 10.1021/acsmedchemlett.7b00161

Source DB:  PubMed          Journal:  ACS Med Chem Lett        ISSN: 1948-5875            Impact factor:   4.345


  25 in total

Review 1.  Biochemical target isolation for novices: affinity-based strategies.

Authors:  Shin-ichi Sato; Asako Murata; Takashi Shirakawa; Motonari Uesugi
Journal:  Chem Biol       Date:  2010-06-25

2.  Concise, Enantioselective, and Versatile Synthesis of (-)-Englerin A Based on a Platinum-Catalyzed [4C+3C] Cycloaddition of Allenedienes.

Authors:  Ronald Nelson; Moisés Gulías; José L Mascareñas; Fernando López
Journal:  Angew Chem Int Ed Engl       Date:  2016-10-13       Impact factor: 15.336

3.  Englerin A stimulates PKCθ to inhibit insulin signaling and to simultaneously activate HSF1: pharmacologically induced synthetic lethality.

Authors:  Carole Sourbier; Bradley T Scroggins; Ranjala Ratnayake; Thomas L Prince; Sunmin Lee; Min-Jung Lee; Peter Literati Nagy; Young H Lee; Jane B Trepel; John A Beutler; W Marston Linehan; Len Neckers
Journal:  Cancer Cell       Date:  2013-01-23       Impact factor: 31.743

4.  Computationally guided organometallic chemistry: preparation of the heptacyclic pyrazine core of ritterazine N.

Authors:  Douglass F Taber; Karen V Taluskie
Journal:  J Org Chem       Date:  2006-03-31       Impact factor: 4.354

5.  Total synthesis of (+/-)-4-demethylenglerin A.

Authors:  Liang Dong; Xiao-Zhen Jiao; Xiao-Yu Liu; Cheng-Sen Tian; Xiao-Yu Li; Yang-Yang Yao; Ping Xie
Journal:  J Asian Nat Prod Res       Date:  2014-06-09       Impact factor: 1.569

6.  Englerin A, a selective inhibitor of renal cancer cell growth, from Phyllanthus engleri.

Authors:  Ranjala Ratnayake; David Covell; Tanya T Ransom; Kirk R Gustafson; John A Beutler
Journal:  Org Lett       Date:  2009-01-01       Impact factor: 6.005

7.  A formal synthesis of (-)-englerin A by relay ring closing metathesis and transannular etherification.

Authors:  Jungyong Lee; Kathlyn A Parker
Journal:  Org Lett       Date:  2012-05-07       Impact factor: 6.005

8.  Englerin a selectively induces necrosis in human renal cancer cells.

Authors:  Florian J Sulzmaier; Zhenwu Li; Mika L Nakashige; David M Fash; William J Chain; Joe W Ramos
Journal:  PLoS One       Date:  2012-10-22       Impact factor: 3.240

9.  Englerin A Agonizes the TRPC4/C5 Cation Channels to Inhibit Tumor Cell Line Proliferation.

Authors:  Cheryl Carson; Pichai Raman; Jennifer Tullai; Lei Xu; Martin Henault; Emily Thomas; Sarita Yeola; Jianmin Lao; Mark McPate; J Martin Verkuyl; George Marsh; Jason Sarber; Adam Amaral; Scott Bailey; Danuta Lubicka; Helen Pham; Nicolette Miranda; Jian Ding; Hai-Ming Tang; Haisong Ju; Pamela Tranter; Nan Ji; Philipp Krastel; Rishi K Jain; Andrew M Schumacher; Joseph J Loureiro; Elizabeth George; Giuliano Berellini; Nathan T Ross; Simon M Bushell; Gül Erdemli; Jonathan M Solomon
Journal:  PLoS One       Date:  2015-06-22       Impact factor: 3.240

Review 10.  Photoaffinity labeling in target- and binding-site identification.

Authors:  Ewan Smith; Ian Collins
Journal:  Future Med Chem       Date:  2015       Impact factor: 3.808

View more
  2 in total

1.  Biological Effects of Modifications of the Englerin A Glycolate.

Authors:  Sarath P D Seenadera; Sarah A Long; Rhone Akee; Gabriela Bermudez; Gregory Parsonage; Jonathan Strope; Cody Peer; W Douglas Figg; Kathlyn A Parker; David J Beech; John A Beutler
Journal:  ACS Med Chem Lett       Date:  2022-08-22       Impact factor: 4.632

2.  Bridgehead Modifications of Englerin A Reduce TRPC4 Activity and Intravenous Toxicity but not Cell Growth Inhibition.

Authors:  Zhenhua Wu; Jean-Simon Suppo; Sarka Tumova; Jonathan Strope; Fernando Bravo; Melody Moy; Ethan S Weinstein; Cody J Peer; William D Figg; William J Chain; Antonio M Echavarren; David J Beech; John A Beutler
Journal:  ACS Med Chem Lett       Date:  2020-08-03       Impact factor: 4.345

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.